An international team of scientists is working on a new drug called DiaPep277 for type 1 diabetes that aims to inhibit the immune system from attacking the pancreas. Treatment could help the organ recover and reproduce sufficient amounts of insulin to support the body, allowing patients to discontinue insulin injections. Trials are under way, and researchers said the drug could be available in three years.

Related Summaries